NEW YORK, July 27, 2018 (GLOBE NEWSWIRE) -- The global mycoplasma testing market was valued at USD 606.9 million in 2017, and is expected to reach USD 1358.2 million by 2024, at a CAGR of 12.3% during 2018-2024. The growth can be primarily attributed to the increasing incidence of mycoplasma contamination, and increasing research and development activities in the field of life sciences. In addition, increasing capital investment in the field of life sciences coupled with stringent regulatory norms to reduce contamination is also projected to drive the market during the forecast period.
Mycoplasma testing providing growth opportunities for the pharmaceutical and biotechnology industry
Cell culture has become an important tool for medical and biological research. In the biotechnology sector, they are increasingly used for drug screening and development, and large-scale manufacturing of biological compounds. Moreover, the application of cell in regenerative medicine, research laboratories, and biotechnological productions is growing extensively. Mycoplasma contamination affects the cell line growth and also affects the cell physiology and metabolism. The contamination may occur via contact with other formerly infected cultures. The mycoplasma contaminates the final biological products such as viral vaccines, immunologic modulators, cytokines, monoclonal antibodies, cell therapy products, resulting in the loss of the batches. Mycoplasma contamination is a significant problem in the biopharmaceutical industry, as it is a common cause of contamination in cell culture. There are various testing methods to confirm mycoplasma contamination such as staining, PCR (polymerase chain reaction), microbial culture techniques, ELISA (enzyme-linked immunosorbent assay), enzymatic methods, among others. All methods give effective results with both infected and non-infected cell lines. With Increasing research and development activities and growing demand for biopharmaceutical products, regulatory bodies such as FDA and EMA are expected to increasingly approve mycoplasma testing for biopharmaceutical products in coming years.
Mycoplasma Testing Market – Regional insight
Geographically, North America held the largest share of the market in 2017. The growth in the region is attributed to the increasing research and development activities in the biopharmaceutical industries and availability of the various types of kit and reagents. Moreover, continued research and development on new assays and kits, and growing demand from end-user industries such as pharmaceutical & biotechnology, cell banks, and contract service laboratories is further boosting the market growth in the region. Europe held the second largest share of the global mycoplasma testing market in 2017. Asia-Pacific is expected to grow at the highest CAGR during 2018-2024. The growth of the mycoplasma testing market in Asia-Pacific region is attributed to growing pharmaceutical and biotechnological industry and strong demand for mycoplasma testing from these sectors. Moreover, technological advancements in mycoplasma testing methods and increasing investment in R&D activities are further propelling the market growth in the region.
Browse full research report with TOC on “Global Mycoplasma Testing Market” Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2024” at: https://www.energiasmarketresearch.com/global-mycoplasma-testing-market-report/
To purchase report: sales@energiasmarketresearch.com
Key findings from the report:
This report segments mycoplasma testing market based on product type, technology, application, end-user and region.
By Product Type
By Technology
By Application
By End-user
By Region
About Energias Market Research Pvt. Ltd.–
Energias Market Research Pvt. Ltd. publishes high quality reports, in-depth market research studies, to help clients obtain investment level clarity on current business scenario, trends and segmentation for their future developments. We are committed to our client’s needs, by providing high quality custom reports solutions best fit for strategy development and implementation to high return of invest (RoI). We believe that exceptional problems need expertise to solve, and with the help of our industries expertise we are able to offer an in depth understanding of what’s crucial, what’s applicable, and what it takes to ensure accomplishment in any business or venture.
With a wide range of expertise from various industrial sectors and more than 50 industries that include energy, chemical and materials, information and communication technology, semiconductor and electronics industries, healthcare and daily consumer goods, etc., we strive to provide our clients with a one-stop solution for all research and consulting needs.
Contact:
Mr. ManasNagi
Business Development Manager
For any queries email us: info@energiasmarketresearch.com
To purchase report: sales@energiasmarketresearch.com
Call us: +1-716-239-4915